Skip to main navigation

Main navigation

Patients
Science
- Our Scientific Approach
- Publications & Presentations
Programs
- Our Pipeline
- Mavacamten
- MYK-224
- LUS-1
- MYK-491
- ACT-1
Researchers
- For Researchers
- Grants & Funding
Investors
Careers
- Become a Myokardian
- Current Opportunities
About

Investors & Media

Menu

Press Releases
Events & Presentations
Analyst Coverage
Investor FAQ
Online Investor Kit

Investor Relations Contact

Michelle Corral
MyoKardia, Inc.
650-351-4690
ir@myokardia.com

SHAREHOLDER TOOLS

PRINT PAGE
E-MAIL ALERTS
SHARE
IR CONTACT
RSS FEEDS

Facebook
Google
LinkedIn
Twitter

Our core values

Patients First
Passion for Science
Succeed Together
Imagine and Innovate
Lifelong Learning

Contact
Terms of Use
Privacy Policy

© 2021 MyoKardia, A Bristol-Myers Squibb Company
All rights reserved.

Main navigation

Patients
Science
- Our Scientific Approach
- Publications & Presentations
Programs
- Our Pipeline
- Mavacamten
- MYK-224
- LUS-1
- MYK-491
- ACT-1
Researchers
- For Researchers
- Grants & Funding
Investors
Careers
- Become a Myokardian
- Current Opportunities
About